🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Ibnsina Pharma Co (ISPH)

Egypt
Currency in EGP
5.350
+0.150(+2.88%)
Closed

ISPH Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa16,600.4618,678.9621,732.8322,264.533,949.33
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+24.59%+12.52%+16.35%+2.45%+52.48%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa15,16117,212.120,103.3120,647.731,434.24
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa1,439.451,466.861,629.521,616.82,515.09
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+28.03%+1.9%+11.09%-0.78%+55.56%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa8.67%7.85%7.5%7.26%7.41%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa786.12978.17962.171,141.581,378.01
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+19.43%+24.43%-1.64%+18.65%+20.71%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa689.23847.05784.091,141.581,373.01
aa.aaaa.aaaa.aaaa.aaaa.aa10.67---5
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa653.33488.69667.35475.221,137.08
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+40.18%-25.2%+36.56%-28.79%+139.28%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa3.94%2.62%3.07%2.13%3.35%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-252.51-255.32-284.18-343.83-917.31
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-110.9%-1.11%-11.3%-20.99%-166.79%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-252.51-255.32-284.18-477.09-1,043.96
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa---133.26126.65
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa1956.4386.2943.1747.76
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa419.82289.8469.46174.55267.53
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa1.062.424.250.750.48
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa---48.37--
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa420.88292.22425.34175.31268.02
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+18.27%-30.57%+45.56%-58.78%+52.88%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa2.54%1.56%1.96%0.79%0.79%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa92.1167.56110.954.4354.74
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa328.77224.66314.4170.87213.27
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa--0.331.710.39
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa328.77224.66314.73172.58213.66
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+25.24%-31.67%+40.09%-45.16%+23.8%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa1.98%1.2%1.45%0.78%0.63%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa59.3440.5528.436.9540.52
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa269.43184.11286.33135.63173.14
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa0.240.160.220.130.17
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+9.51%-31.67%+33.78%-38.82%+27.65%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa0.240.160.220.130.17
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+9.51%-31.67%+33.78%-38.82%+27.65%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,119.991,119.991,301.991,0081,008
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,119.991,119.991,301.991,0081,008
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa--0.09--
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa723.44601.49784.78589.261,251.26
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+43.21%-16.86%+30.47%-24.91%+112.34%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa4.36%3.22%3.61%2.65%3.69%
EBIT
aa.aaaa.aaaa.aaaa.aaaa.aa653.33488.69667.35475.221,137.08
* In Millions of EGP (except for per share items)